<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39391865</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2673-5601</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Immuno</Title><ISOAbbreviation>Immuno</ISOAbbreviation></Journal><ArticleTitle>A Serological Multiplexed Immunoassay (MIA) Detects Antibody Reactivity to SARS-CoV-2 and Other Viral Pathogens in Liberia and Is Configurable as a Multiplexed Inhibition Test (MINT).</ArticleTitle><Pagination><StartPage>108</StartPage><EndPage>124</EndPage><MedlinePgn>108-124</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/immuno4010007</ELocationID><Abstract><AbstractText>The SARS-CoV-2 pandemic ignited global efforts to rapidly develop testing, therapeutics, and vaccines. However, the rewards of these efforts were slow to reach many low- to middle-income countries (LMIC) across the African continent and globally. Therefore, two bead-based multiplexed serological assays were developed to determine SARS-CoV-2 exposure across four counties in Liberia. This study was conducted during the summer of 2021 on 189 samples collected throughout Grand Bassa, Bong, Margibi, and Montserrado counties. Our multiplexed immunoassay (MIA) detected elevated exposure to SARS-CoV-2 and multiple variant antigens. Additionally, we detected evidence of exposure to Dengue virus serotype 2, Chikungunya virus, and the seasonal coronavirus NL63. Our multiplexed inhibition test (MINT) was developed from the MIA to observe antibody-mediated inhibition of SARS-CoV-2 spike protein binding to its cognate cellular receptor ACE-2. We detected inhibitory antibodies in the tested Liberian samples, which were collectively consistent with a convalescent serological profile. These complementary assays serve to supplement existing serological testing needs and may enhance the technical capacity of scientifically underrepresented regions globally.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Haun</LastName><ForeName>Brien K</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>To</LastName><ForeName>Albert</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7118-9803</Identifier><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Caitlin A</ForeName><Initials>CA</Initials><Identifier Source="ORCID">0000-0002-2126-5089</Identifier><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ball</LastName><ForeName>Aquena</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fong</LastName><ForeName>Karalyn</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Teri Ann S</ForeName><Initials>TAS</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shobayo</LastName><ForeName>Bode</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-4864-0248</Identifier><AffiliationInfo><Affiliation>National Public Health Institute of Liberia, Monrovia 1000, Liberia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teahton</LastName><ForeName>Julius</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Public Health Institute of Liberia, Monrovia 1000, Liberia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ching</LastName><ForeName>Lauren</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamara</LastName><ForeName>Varney</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Sciences, Medical Science, TJR Faulkner College of Science and Technology, University of Liberia, Fendall 1000, Liberia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tekah</LastName><ForeName>Davidetta M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, Medical Science, TJR Faulkner College of Science and Technology, University of Liberia, Fendall 1000, Liberia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Humphrey</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, Medical Science, TJR Faulkner College of Science and Technology, University of Liberia, Fendall 1000, Liberia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berestecky</LastName><ForeName>John</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0007-4917-991X</Identifier><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Sciences, Medical Science, TJR Faulkner College of Science and Technology, University of Liberia, Fendall 1000, Liberia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Math Science Department, Kapiolani Community College, University of Hawaii, Honolulu, HI 96816, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nerurkar</LastName><ForeName>Vivek R</ForeName><Initials>VR</Initials><Identifier Source="ORCID">0000-0002-2044-2784</Identifier><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehrer</LastName><ForeName>Axel T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 GM114737</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HL115505</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 GH002256</GrantID><Acronym>GH</Acronym><Agency>CGH CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>D71 TW010434</GrantID><Acronym>TW</Acronym><Agency>FIC NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI132323</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Immuno</MedlineTA><NlmUniqueID>9918350785906676</NlmUniqueID><ISSNLinking>2673-5601</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CHIKV</Keyword><Keyword MajorTopicYN="N">DENV-2</Keyword><Keyword MajorTopicYN="N">Liberia</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">West-Africa</Keyword><Keyword MajorTopicYN="N">antibodies</Keyword><Keyword MajorTopicYN="N">hCoV-NL63</Keyword><Keyword MajorTopicYN="N">inhibition</Keyword><Keyword MajorTopicYN="N">serological</Keyword><Keyword MajorTopicYN="N">surveillance</Keyword></KeywordList><CoiStatement>Conflicts of Interest: The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>4</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39391865</ArticleId><ArticleId IdType="mid">NIHMS2026013</ArticleId><ArticleId IdType="pmc">PMC11465787</ArticleId><ArticleId IdType="doi">10.3390/immuno4010007</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nkengasong J Let Africa into the market for COVID-19 diagnostics. Nature 2020, 580, 565–566.</Citation><ArticleIdList><ArticleId IdType="pubmed">32346145</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong E; Du H; Gardner L An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis 2020, 20, 533–534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Mertens P; De Vos N; Martiny D; Jassoy C; Mirazimi A; Cuypers L; Van den Wijngaert S; Monteil V; Melin P; Stoffels K; et al. Development and Potential Usefulness of the COVID-19 Ag Respi-Strip Diagnostic Assay in a Pandemic Context. Front. Med 2020, 7, 225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7227790</ArticleId><ArticleId IdType="pubmed">32574326</ArticleId></ArticleIdList></Reference><Reference><Citation>Porte L; Legarraga P; Vollrath V; Aguilera X; Munita JM; Araos R; Pizarro G; Vial P; Iruretagoyena M; Dittrich S; et al. Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples. Int. J. Infect. Dis 2020, 99, 328–333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7263236</ArticleId><ArticleId IdType="pubmed">32497809</ArticleId></ArticleIdList></Reference><Reference><Citation>Candel González FJ; Viñuela-Prieto JM; González Del Castillo J; Barreiro García P; Fragiel Saavedra M; Hernández Píriz A; Jiménez Virumbrales D; Canora Lebrato J; García De Casasola G; Gil Prieto R; et al. Utility of lateral flow tests in SARS-CoV-2 infection monitorization. Rev. Española De Quimioter 2020, 33, 258–266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7374028</ArticleId><ArticleId IdType="pubmed">32492991</ArticleId></ArticleIdList></Reference><Reference><Citation>Peto T; Team UC-LFO COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing. EClinicalMedicine 2021, 36, 100924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8164528</ArticleId><ArticleId IdType="pubmed">34101770</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman T; Kolstad L; Lindahl JF; Albinsson B; Bergqvist A; Rönnberg B; Lundkvist Å Diagnostic Potential of a Luminex-Based Coronavirus Disease 2019 Suspension Immunoassay (COVID-19 SIA) for the Detection of Antibodies against SARS-CoV-2. Viruses 2021, 13, 993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8227055</ArticleId><ArticleId IdType="pubmed">34073484</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina LO; To A; Lieberman MM; Wong TAS; Namekar M; Nakano E; Andersen H; Yalley-Ogunro J; Greenhouse J; Higgs S; et al. A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human Primates. Front. Immunol 2018, 9, 2464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6236113</ArticleId><ArticleId IdType="pubmed">30467501</ArticleId></ArticleIdList></Reference><Reference><Citation>Haun BK; Kamara V; Dweh AS; Garalde-Machida K; Forkay SSE; Takaaze M; Namekar M; Wong TAS; Bell-Gam Woto AER; Humphreys P; et al. Serological evidence of Ebola virus exposure in dogs from affected communities in Liberia: A preliminary report. PLoS Negl. Trop. Dis 2019, 13, e0007614.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6684096</ArticleId><ArticleId IdType="pubmed">31329600</ArticleId></ArticleIdList></Reference><Reference><Citation>Haun BK; Lai CY; Williams CA; Wong TAS; Lieberman MM; Pessaint L; Andersen H; Lehrer AT CoVaccine HT Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization. Front. Immunol 2020, 11, 599587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7661386</ArticleId><ArticleId IdType="pubmed">33193454</ArticleId></ArticleIdList></Reference><Reference><Citation>To A; Wong TAS; Lieberman MM; Thompson K; Ball AH; Pessaint L; Greenhouse J; Daham N; Cook A; Narvaez B; et al. A Recombinant Subunit Vaccine Induces a Potent, Broadly Neutralizing, and Durable Antibody Response in Macaques against the SARS-CoV-2 P.1 (Gamma) Variant. ACS Infect. Dis 2022, 8, 825–840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938837</ArticleId><ArticleId IdType="pubmed">35263081</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar M; Roe K; Nerurkar PV; Namekar M; Orillo B; Verma S; Nerurkar VR Impaired virus clearance, compromised immune response and increased mortality in type 2 diabetic mice infected with West Nile virus. PLoS ONE 2012, 7, e44682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3432127</ArticleId><ArticleId IdType="pubmed">22953001</ArticleId></ArticleIdList></Reference><Reference><Citation>Namekar M; Kumar M; O’Connell M; Nerurkar VR Effect of serum heat-inactivation and dilution on detection of anti-WNV antibodies in mice by West Nile virus E-protein microsphere immunoassay. PLoS ONE 2012, 7, e45851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3457982</ArticleId><ArticleId IdType="pubmed">23049879</ArticleId></ArticleIdList></Reference><Reference><Citation>Sancilio AE; D’Aquila RT; McNally EM; Velez MP; Ison MG; Demonbreun AR; McDade TW A surrogate virus neutralization test to quantify antibody-mediated inhibition of SARS-CoV-2 in finger stick dried blood spot samples. Sci. Rep 2021, 11, 15321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8319431</ArticleId><ArticleId IdType="pubmed">34321523</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW; Chia WN; Qin X; Liu P; Chen MIC; Tiu C; Hu Z; Chen VC-W; Young BE; Sia WR; et al. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction. Nat. Biotechnol 2020, 38, 1073–1078.</Citation><ArticleIdList><ArticleId IdType="pubmed">32704169</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisnewski AV; Liu J; Lucas C; Klein J; Iwasaki A; Cantley L; Fazen L; Campillo Luna J; Slade M; Redlich CA Development and utilization of a surrogate SARS-CoV-2 viral neutralization assay to assess mRNA vaccine responses. PLoS ONE 2022, 17, e0262657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8765639</ArticleId><ArticleId IdType="pubmed">35041700</ArticleId></ArticleIdList></Reference><Reference><Citation>Embregts CWE; Verstrepen B; Langermans JAM; Boszormenyi KP; Sikkema RS; de Vries RD; Hoffmann D; Wernike K; Smit LAM; Zhao S; et al. Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test. One Health 2021, 13, 100313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8378998</ArticleId><ArticleId IdType="pubmed">34458548</ArticleId></ArticleIdList></Reference><Reference><Citation>Ching LL; Tseng AC; Nakano E; Salomon RC; Wang WK; Shikuma C; Nerurkar VR COVID-19 vaccination and booster induced authentic-virus neutralizing antibody response is superior to SARS-CoV-2 natural infection induced response. J. Clin. Virol 2022, 152, 105185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9107334</ArticleId><ArticleId IdType="pubmed">35605371</ArticleId></ArticleIdList></Reference><Reference><Citation>To A; Medina LO; Mfuh KO; Lieberman MM; Wong TAS; Namekar M; Nakano E; Lai CY; Kumar M; Nerurkar VR; et al. Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in Mice. mSphere 2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5760751</ArticleId><ArticleId IdType="pubmed">29359186</ArticleId></ArticleIdList></Reference><Reference><Citation>Shobayo B; Mishra M; Sameroff S; Petrosov A; Ng J; Gokden A; Macauley J; Jain K; Renken C; Duworko JT; et al. SARS-CoV-2 Sequence Analysis during COVID-19 Case Surge, Liberia, 2021. Emerg. Infect. Dis 2021, 27, 3185–3188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8632187</ArticleId><ArticleId IdType="pubmed">34708683</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrie MB; Lakoh S; Kelly JD; Kanu JS; Squire JS; Koroma Z; Bah S; Sankoh O; Brima A; Ansumana R; et al. SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: A cross-sectional, nationally representative, age-stratified serosurvey. BMJ Glob. Health 2021, 6, e007271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8587532</ArticleId><ArticleId IdType="pubmed">34764148</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller DA; Young PR The flavivirus NS1 protein: Molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker. Antivir. Res 2013, 98, 192–208.</Citation><ArticleIdList><ArticleId IdType="pubmed">23523765</ArticleId></ArticleIdList></Reference><Reference><Citation>Akpan GE; Bawo L; Amo-Addae M; Kennedy J; Wesseh CS; Whesseh F; Adewuyi P; Sanvee-Blebo L; Babalola J; Sesay HWW; et al. COVID-19 reinfection in Liberia: Implication for improving disease surveillance. PLoS ONE 2022, 17, e0265768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8947140</ArticleId><ArticleId IdType="pubmed">35324956</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang JW; Lam TT; Zaraket H; Lipkin WI; Drews SJ; Hatchette TF; Heraud JM; Koopmans MP; INSPIRE investigators. Global epidemiology of non-influenza RNA respiratory viruses: Data gaps and a growing need for surveillance. Lancet Infect. Dis 2017, 17, e320–e326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164797</ArticleId><ArticleId IdType="pubmed">28457597</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan X; Wang Z; Wang X; Zhang X; Wang L; Lu Z; Jia Z Association between human coronaviruses’ epidemic and environmental factors on a global scale. Environ. Sci. Pollut. Res 2022, 29, 14333–14347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8490851</ArticleId><ArticleId IdType="pubmed">34609683</ArticleId></ArticleIdList></Reference><Reference><Citation>Edridge AWD; Kaczorowska J; Hoste ACR; Bakker M; Klein M; Loens K; Jebbink MF; Matser A; Kinsella CM; Rueda P; et al. Seasonal coronavirus protective immunity is short-lasting. Nat. Med 2020, 26, 1691–1693.</Citation><ArticleIdList><ArticleId IdType="pubmed">32929268</ArticleId></ArticleIdList></Reference><Reference><Citation>Waterlow NR; van Leeuwen E; Davies NG; Group CC-W; Flasche S; Eggo RM How immunity from and interaction with seasonal coronaviruses can shape SARS-CoV-2 epidemiology. Proc. Natl. Acad. Sci. USA 2021, 118, e2108395118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8670441</ArticleId><ArticleId IdType="pubmed">34873059</ArticleId></ArticleIdList></Reference><Reference><Citation>Galipeau Y; Siragam V; Laroche G; Marion E; Greig M; McGuinty M; Booth RA; Durocher Y; Cuperlovic-Culf M; Bennett SAL; et al. Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2. EBioMedicine 2021, 74, 103700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8629681</ArticleId><ArticleId IdType="pubmed">34861490</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagar M; Reifler K; Rossi M; Miller NS; Sinha P; White LF; Mizgerd JP Recent endemic coronavirus infection is associated with less-severe COVID-19. J. Clin. Investig 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7773342</ArticleId><ArticleId IdType="pubmed">32997649</ArticleId></ArticleIdList></Reference><Reference><Citation>Borrega R; Nelson DKS; Koval AP; Bond NG; Heinrich ML; Rowland MM; Lathigra R; Bush DJ; Aimukanova I; Phinney WN; et al. Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans. Viruses 2021, 13, 2325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8625389</ArticleId><ArticleId IdType="pubmed">34835131</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoussi EB; Ehui E; Kassi NA; Kouakou G; Nouhou Y; Adjogoua EV; Eholie S; Bissagnene E Seven native cases of dengue in Abidjan, Ivory Coast. Med. Mal. Infect 2014, 44, 433–436.</Citation><ArticleIdList><ArticleId IdType="pubmed">25239146</ArticleId></ArticleIdList></Reference><Reference><Citation>Dariano DF; Taitt CR; Jacobsen KH; Bangura U; Bockarie AS; Bockarie MJ; Lahai J; Lamin JM; Leski TA; Yasuda C; et al. Surveillance of Vector-Borne Infections (Chikungunya, Dengue, and Malaria) in Bo, Sierra Leone, 2012–2013. Am. J. Trop. Med. Hyg 2017, 97, 1151–1154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5637587</ArticleId><ArticleId IdType="pubmed">29031286</ArticleId></ArticleIdList></Reference><Reference><Citation>De Araújo Lobo JM; Mores CN; Bausch DG; Christofferson RC Short Report: Serological Evidence of Under-Reported Dengue Circulation in Sierra Leone. PLoS Neglected Trop. Dis 2016, 10, e0004613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4846026</ArticleId><ArticleId IdType="pubmed">27116605</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt S; Gething PW; Brady OJ; Messina JP; Farlow AW; Moyes CL; Drake JM; Brownstein JS; Hoen AG; Sankoh O; et al. The global distribution and burden of dengue. Nature 2013, 496, 504–507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3651993</ArticleId><ArticleId IdType="pubmed">23563266</ArticleId></ArticleIdList></Reference><Reference><Citation>Were F The dengue situation in Africa. Paediatr. Int. Child. Health 2012, 32 (Suppl. S1), 18–21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3381440</ArticleId><ArticleId IdType="pubmed">22668445</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo G; Subissi L; Rezza G Chikungunya fever in Africa: A systematic review. Pathog. Glob. Health 2020, 114, 136–144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7241529</ArticleId><ArticleId IdType="pubmed">32308158</ArticleId></ArticleIdList></Reference><Reference><Citation>Conzelmann C; Gilg A; Gross R; Schutz D; Preising N; Standker L; Jahrsdorfer B; Schrezenmeier H; Sparrer KMJ; Stamminger T; et al. An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection. Antivir. Res 2020, 181, 104882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7388004</ArticleId><ArticleId IdType="pubmed">32738255</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller K; Girl P; von Buttlar H; Dobler G; Wolfel R Comparison of two commercial surrogate ELISAs to detect a neutralising antibody response to SARS-CoV-2. J. Virol. Methods 2021, 292, 114122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7938787</ArticleId><ArticleId IdType="pubmed">33705832</ArticleId></ArticleIdList></Reference><Reference><Citation>Wouters E; Verbrugghe C; Devloo R; Debruyne I; De Clippel D; Van Heddegem L; Van Asch K; Van Gaver V; Vanbrabant M; Muylaert A; et al. A novel competition ELISA for the rapid quantification of SARS-CoV-2 neutralizing antibodies in convalescent plasma. Transfusion 2021, 61, 2981–2990.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662007</ArticleId><ArticleId IdType="pubmed">34498761</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunau B; Prusinkiewicz M; Asamoah-Boaheng M; Golding L; Lavoie PM; Petric M; Levett PN; Haig S; Barakauskas V; Karim ME; et al. Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals. Microbiol. Spectr 2022, 10, e0131522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9602390</ArticleId><ArticleId IdType="pubmed">36121252</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohmer N; Westhaus S; Ruhl C; Ciesek S; Rabenau HF Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays. J. Clin. Virol 2020, 129, 104480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7263247</ArticleId><ArticleId IdType="pubmed">32505777</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee B; Ko J-H; Park J; Moon H-W; Baek JY; Jung S; Lim H-Y; Kim K-C; Huh K; Cho SY; et al. Estimating the Neutralizing Effect and Titer Correlation of Semi-Quantitative Anti-SARS-CoV-2 Antibody Immunoassays. Front. Cell. Infect. Microbiol 2022, 12, 822599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046723</ArticleId><ArticleId IdType="pubmed">35493733</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H-J; Jung J; Lee JH; Lee D-G; Kim YB; Oh E-J Comparison of Six Serological Immunoassays for the Detection of SARS-CoV-2 Neutralizing Antibody Levels in the Vaccinated Population. Viruses 2022, 14, 946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9147836</ArticleId><ArticleId IdType="pubmed">35632688</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L; Hall T; Ssewanyana I; Oulton T; Patterson C; Vasileva H; Singh S; Affara M; Mwesigwa J; Correa S; et al. Optimisation and standardisation of a multiplex immunoassay of diverse Plasmodium falciparum antigens to assess changes in malaria transmission using sero-epidemiology. Wellcome Open Res. 2019, 4, 26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255915</ArticleId><ArticleId IdType="pubmed">32518839</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>